MAP2K7 and lung carcinoma: The results showed that EGFR signaling could govern MEK/ERK pathway more strongly, however, the situation is not the same in BRAFV600E mutant lung cancer, which induce the receptor tyrosine kinases (RTKs) resistance problem (75).